LifeMD price to free cash flow LFMD
Market value divided by free cash flow over the last twelve months, since 2023.
- Today, Nov 2, 2026
- n/m
- not a meaningful number
- Last meaningful
- 44.5×
- Jul 2026
- 3-year median
- 17.8×
- 3-year range
- 10.0× to 309×
- Peer median
- 12.3×
LifeMD's price to free cash flow is not a meaningful number today: free cash flow over the last twelve months was zero, negative or not reported.
It was last meaningful in Jul 2026, at 44.5×.
On the days it had one over the last 3 years, its median was 17.8×, from 10.0× in Mar 2025 to 309× in Dec 2023.
Price to free cash flow over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 44.5× | 11.5× | 62.2× |
| 2025 | 15.1× | 10.0× | 48.1× |
| 2024 | 11.1× | 10.8× | 288× |
| 2023 | 298× | 242× | 309× |
Against its peers
Companies in Medical - Care Facilities nearest LifeMD's size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| LFMDLifeMD | n/m |
| CYHCommunity Health Systems | n/m |
| VMDViemed Healthcare | 12.3× |
| SBCSBC Medical | 8.8× |
| OMDAOmada Health | 48.1× |
| Peer median | 12.3× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on LifeMD
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.